Medical distributor McKesson Corporation (NYSE:MCK) announced on Thursday an agreement to sell its Canada-based drugstore chain Rexall and online retailer Well.ca to Canadian private equity firm Birch Hill Equity Partners.

McKesson (MCK) said the divestment is expected to help the company focus more on its oncology and biopharma services platforms, in line with its enterprise strategy.

“We remain fully committed to and confident in the strength of our Canadian distribution and biopharma businesses,” CEO Brian Tyler added.

Despite the sale, the company plans to remain a wholesale distribution supplier to Rexall and Well.ca. Financial terms of the transaction were not disclosed.

Early this year, Reuters reported that McKesson (MCK) was planning to sell Rexall seven years after the company bought the unit for about C$3B ($2.2B). In 2017, MCK acquired Well.ca, an online marketplace for health, wellness, natural, and baby products.